InMode (INMD) Net Shares Issued and Repurchased (2020 - 2026)
InMode (INMD) posted Net Shares Issued and Repurchased of -$31.2 million for Q1 2026, down 13.67% sequentially from -$27.5 million in Q2 2025, and up 68.75% YoY from -$18.5 million in Q1 2025.
InMode (INMD) Net Shares Issued and Repurchased (2020 - 2026) Analysis & Trends
InMode has reported Net Shares Issued and Repurchased for 6 years, with the latest figure at -$31.2 million in Q1 2026.
- Quarterly Net Shares Issued and Repurchased rose 68.75% year-over-year to -$31.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$58.7 million (up 84.76% YoY) and the FY2025 annual result came in at -$127.4 million, up 55.34% from the prior year.
- Net Shares Issued and Repurchased retreated to -$31.2 million in Q1 2026 per INMD's latest filing, from -$27.5 million in the prior quarter.
- Over five years, Net Shares Issued and Repurchased peaked at -$27.5 million in Q2 2025 and troughed at -$119.8 million in Q4 2024.
- A 4-year average of -$69.5 million and a median of -$76.6 million in 2024 frame the typical range for Net Shares Issued and Repurchased.
- The sharpest annual moves came in 2022 and 2025: Net Shares Issued and Repurchased tumbled 4834.84% in 2022, then surged 69.11% in 2025.
- Over 4 years, Net Shares Issued and Repurchased stood at -$42.6 million in 2022, then slumped by 181.09% to -$119.8 million in 2024, then soared by 77.07% to -$27.5 million in 2025, then fell by 13.67% to -$31.2 million in 2026.
- According to Business Quant data, Net Shares Issued and Repurchased over the past three periods registered -$31.2 million, -$27.5 million, and -$100.0 million for Q1 2026, Q2 2025, and Q1 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Shares Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.07 Bn | 193.46 Bn | 7.27 Bn | - |
| 2 | Stryker | 127.90 Bn | 124.43 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.84 Bn | 109.62 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 73.33 Bn | 72.79 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.46 Bn | 32.51 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.81 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | -79.04 Mn |
| 9 | Steris | 23.12 Bn | 22.64 Bn | 684.20 Mn | - |
| 10 | InMode | 910.68 Mn | 495.51 Mn | 71.52 Mn | -56.51 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -31.24 Mn |
| Mar 31, 2026 | -31.24 Mn |
| Jun 30, 2025 | -27.48 Mn |
| Jun 30, 2025 | -27.48 Mn |
| Mar 31, 2025 | -99.96 Mn |
| Mar 31, 2025 | -99.96 Mn |
| Dec 31, 2024 | -119.85 Mn |
| Dec 31, 2024 | -119.85 Mn |
| Sep 30, 2024 | -76.56 Mn |
| Sep 30, 2024 | -76.56 Mn |
| Jun 30, 2024 | -88.98 Mn |
| Jun 30, 2024 | -88.98 Mn |
| Mar 31, 2022 | -42.64 Mn |
| Mar 31, 2022 | -42.64 Mn |
| Dec 31, 2021 | -23.44 Mn |
| Dec 31, 2021 | -23.44 Mn |
| Jun 30, 2021 | -11.06 Mn |
| Jun 30, 2021 | -11.06 Mn |
| Mar 31, 2021 | -864,000.00 |
| Mar 31, 2021 | -864,000.00 |